Cargando…
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19
Coronavirus disease 2019 (COVID-19), caused by SARS coronavirus 2 (SARS-CoV-2), is spreading rapidly with no established effective treatments. While most cases are mild, others experience uncontrolled inflammatory responses with oxidative stress, dysregulation of iron and coagulation as features. La...
Autores principales: | Mann, Jaclyn Kelly, Ndung'u, Thumbi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543043/ http://dx.doi.org/10.2217/fvl-2020-0170 |
Ejemplares similares
-
HIV-1 vaccine immunogen design strategies
por: Mann, Jaclyn K, et al.
Publicado: (2015) -
Providing New Insights on the Molecular Properties and Thermal Stability of Ovotransferrin and Lactoferrin
por: Zeng, Qi, et al.
Publicado: (2023) -
Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C
por: Mann, Jaclyn K., et al.
Publicado: (2015) -
COVID-19 in Africa: preexisting immunity and HIV
por: Snyman, Jumari, et al.
Publicado: (2021) -
Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus
por: Małaczewska, Joanna, et al.
Publicado: (2019)